Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Similar articles for PubMed (Select 15985780)

1.

Assessing homeopathic proving using questionnaire methodology: consideration and implications for future studies.

Brien S, Lewith G.

Forsch Komplementarmed Klass Naturheilkd. 2005 Jun;12(3):152-8. Epub 2005 Jun 23. Review.

PMID:
15985780
2.

Ultramolecular homeopathy has no observable clinical effects. A randomized, double-blind, placebo-controlled proving trial of Belladonna 30C.

Brien S, Lewith G, Bryant T.

Br J Clin Pharmacol. 2003 Nov;56(5):562-8. Erratum in: Br J Clin Pharmacol. 2004 Jan;57(1):117.

3.
4.

Double-blind, placebo-controlled homeopathic pathogenetic trials: symptom collection and analysis.

Dominici G, Bellavite P, di Stanislao C, Gulia P, Pitari G.

Homeopathy. 2006 Jul;95(3):123-30.

PMID:
16815514
5.
6.

Homeopathic proving symptoms: result of a local, non-local, or placebo process? A blinded, placebo-controlled pilot study.

Walach H, Sherr J, Schneider R, Shabi R, Bond A, Rieberer G.

Homeopathy. 2004 Oct;93(4):179-85.

PMID:
15532695
7.

A systematic review of the quality of homeopathic pathogenetic trials published from 1945 to 1995.

Dantas F, Fisher P, Walach H, Wieland F, Rastogi DP, Teixeira H, Koster D, Jansen JP, Eizayaga J, Alvarez ME, Marim M, Belon P, Weckx LL.

Homeopathy. 2007 Jan;96(1):4-16. Review.

PMID:
17227742
8.

The effects of homeopathic belladonna 30CH in healthy volunteers -- a randomized, double-blind experiment.

Walach H, Köster H, Hennig T, Haag G.

J Psychosom Res. 2001 Mar;50(3):155-60.

PMID:
11316508
9.

Protocol for a phase 1 homeopathic drug proving trial.

Teut M, Hirschberg U, Luedtke R, Schnegg C, Dahler J, Albrecht H, Witt CM.

Trials. 2010 Jul 22;11:80. doi: 10.1186/1745-6215-11-80.

10.
11.
12.

Nineteenth-century controlled trials to test whether belladonna prevents scarlet fever.

Chalmers I, Toth B.

J R Soc Med. 2009 Dec;102(12):549-50. doi: 10.1258/jrsm.2009.09k040. No abstract available.

13.

Presentiment or entanglement? An alternative explanation for apparent entanglement in provings.

Lewith GT, Brien S, Hyland ME.

Homeopathy. 2005 Apr;94(2):92-5. Review.

PMID:
15892489
14.

Classical and new proving methodology: provings of Plumbum metallicum and Piper methysticum and comparison with a classical proving of Plumbum metallicum.

Signorini A, Lubrano A, Manuele G, Fagone G, Vittorini C, Boso F, Vianello P, Rebuffi A, Frongia T, Rocco V, Pichler C.

Homeopathy. 2005 Jul;94(3):164-74.

PMID:
16060202
15.

Semi-standardised homeopathic treatment of premenstrual syndrome with a limited number of medicines: feasibility study.

Klein-Laansma CT, Jansen JC, van Tilborgh AJ, Van der Windt DA, Mathie RT, Rutten AL.

Homeopathy. 2010 Jul;99(3):192-204. doi: 10.1016/j.homp.2010.05.007.

PMID:
20674844
16.
17.

Assessing likelihood ratio of clinical symptoms: handling vagueness.

Rutten AL, Stolper CF, Lugten RF, Barthels RW.

Homeopathy. 2003 Oct;92(4):182-6. Review.

PMID:
14587683
18.

Systematic review of homeopathic pathogenetic trials: an excess of rigour?

Sherr J, Quirk T.

Homeopathy. 2007 Oct;96(4):273-5; discussion 275-6, 278. No abstract available.

PMID:
17954386
19.

Homeopathic remedies as metaphors in family therapy. A narrative-based approach to homeopathy.

Konitzer M, Renée A, Doering T.

Homeopathy. 2003 Apr;92(2):77-83.

PMID:
12725249
20.

Translating a nonlinear systems theory model for homeopathy into empirical tests.

Bell IR, Baldwin CM, Schwartz GE.

Altern Ther Health Med. 2002 May-Jun;8(3):58-66. Review.

PMID:
12017501
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk